688302 海创药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.850-12.169-15.590-19.926-25.400
总资产报酬率 ROA (%)-2.302-10.276-13.984-18.233-22.191
投入资产回报率 ROIC (%)-2.580-11.393-15.252-19.603-24.075

边际利润分析
销售毛利率 (%)99.81898.6188.428--53.571
营业利润率 (%)-113.245-666.148-54,378.903---18,261.390
息税前利润/营业总收入 (%)-111.740-701.511-57,305.242---18,717.369
净利润/营业总收入 (%)-114.818-670.510-54,382.772---18,264.523

收益指标分析
经营活动净收益/利润总额(%)118.515121.841108.868110.388112.894
价值变动净收益/利润总额(%)-6.359-11.185-6.571-8.443-9.582
营业外收支净额/利润总额(%)1.3590.6480.0010.0020.017

偿债能力分析
流动比率 (X)7.0427.1996.02610.73711.653
速动比率 (X)7.0057.1766.02610.73711.653
资产负债率 (%)19.60718.79712.4378.3458.627
带息债务/全部投入资本 (%)7.2257.6361.734-0.3471.502
股东权益/带息债务 (%)1,251.2561,186.9275,561.381-28,589.6436,511.928
股东权益/负债合计 (%)410.021432.012704.0761,098.2881,059.170
利息保障倍数 (X)-36.43922.61819.58625.53041.333

营运能力分析
应收账款周转天数 (天)5.3300.0470.000--0.000
存货周转天数 (天)7,160.9821,813.9155.430--2.676